1998
DOI: 10.1093/bja/81.2.247
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of ropivacaine with bupivacaine for paediatric caudal block

Abstract: In a double-blind, multicentre study 245 children aged 1-10 yr undergoing elective minor surgery as inpatients were randomly allocated to receive a single caudal extradural injection of 1 ml kg-1 of either 0.25% bupivacaine or 0.2% ropivacaine after induction of light general anaesthesia. The groups were comparable for age, weight, vital signs and duration of surgery. The onset time was similar for ropivacaine and bupivacaine (9.7 vs 10.4 min). Further analgesia was not required in 40% of children. The mean ti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
65
0
4

Year Published

1999
1999
2015
2015

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 105 publications
(74 citation statements)
references
References 5 publications
5
65
0
4
Order By: Relevance
“…4,5 Although still not registered by the Food and Drug Administration (FDA) for pediatric use (Ͻ 12 years of age), ropivacaine, as well as to some extent levo-bupivacaine, has been compared with racemic bupivacaine in children. [6][7][8][9][10][11][12] However, no investigation has so far compared all 3 preparations in a prospective, randomized fashion.…”
mentioning
confidence: 99%
“…4,5 Although still not registered by the Food and Drug Administration (FDA) for pediatric use (Ͻ 12 years of age), ropivacaine, as well as to some extent levo-bupivacaine, has been compared with racemic bupivacaine in children. [6][7][8][9][10][11][12] However, no investigation has so far compared all 3 preparations in a prospective, randomized fashion.…”
mentioning
confidence: 99%
“…Among different doses of ropivacaine, 0.25% 1 ml kg -1 showed superior postoperative analgesia [8] and significantly lower incidence of motor block [5]. In our study, Isoflurane was used as inhalation agent in Group G, Isoflurane decreases systemic vascular resistance and so reduces blood pressure and causes tachycardia.…”
Section: Discussionmentioning
confidence: 61%
“…Seventeen such RCTs were reviewed in detail using a structured methodology. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] Two review articles were also identified. 18,19 The reference lists for all of these 19 publications were reviewed to identify any further RCTs that may have been missed with the initial search strategy; no such study was found.…”
Section: Methodsmentioning
confidence: 99%